The effect of hemostasis powder® on the amount of bleeding during dacryocystorhinostomy surgery

Investigating the effect of hemostasis powder® on the amount of bleeding during dacryocystorhinostomy surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241110063664N1

Enrollment

Registered

2025-05-28

Start date

2025-07-23

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tear duct obstruction. Diseases of the eye and adnexa

Interventions

Intervention 1: Intervention group: There are people who will use hemostatic powder to control bleeding during dacryocystorhinostomy surgery. Intervention 2: Control group: This includes people who wi

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Minimum age 18 years

Exclusion criteria

Exclusion criteria: Coagulation problems Using anticoagulant medications

Design outcomes

Primary

Measure	Time frame
Reducing bleeding during dacrocystorhinostomy surgery. Timepoint: The amount of bleeding is measured from the beginning of the procedure to the end of the dacryocystorhinostomy procedure. Method of measurement: The amount of bleeding will be measured and recorded by subtracting the volume of the desired solutions and fluids used to wash the surgical site from the total amount of fluid in the suction device.	—

Measure

Time frame

Reducing bleeding during dacrocystorhinostomy surgery. Timepoint: The amount of bleeding is measured from the beginning of the procedure to the end of the dacryocystorhinostomy procedure. Method of measurement: The amount of bleeding will be measured and recorded by subtracting the volume of the desired solutions and fluids used to wash the surgical site from the total amount of fluid in the suction device.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Sabbaghi

Mashhad University of Medical Sciences

hashemiy1@mums.ac.ir0517289912

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026